RVLP

RVL Pharmaceuticals (RVLP)

RVL Pharmaceuticals PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RVLP

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/01/18	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/12/21	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/11/27	20:50	GlobeNewswire Inc.	RVL Completes Financial Restructuring	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/11/16	23:11	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/11/02	05:27	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/24	05:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/24	02:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/21	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/21	04:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/21	02:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/19	05:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/14	06:28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/14	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/10/12	19:50	GlobeNewswire Inc.	RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/30	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/23	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/06	05:18	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/06	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/05	20:45	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/09/01	03:23	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/30	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/26	06:21	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/26	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/24	06:30	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/24	05:05	GlobeNewswire Inc.	RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/19	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/18	06:06	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/18	06:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/18	05:05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RVLP	RVL Pharmaceuticals PLC
2023/08/16	21:00	GlobeNewswire Inc.	RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	NASDAQ:RVLP	RVL Pharmaceuticals PLC